Creating adequate pulsatility with a continuous flow left ventricular assist device: Just do it!

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose of review Continuous flow left ventricular assist devices (LVADs) have revolutionized the treatment of advanced heart failure; however, as experience with these devices has grown, a number of unanticipated adverse events have emerged. In this study, we review the current literature associating a lack of pulsatility with these events. Recent findings It is now evident that continuous flow LVAD physiology reflects a spectrum of 'low pulsatile' rather than a truly 'nonpulsatile' state. Thus, the detrimental consequences of nonpulsatile flow noted in early experimental setups may or may not occur in humans supported with continuous flow LVADs. Such studies have demonstrated not only alterations in vascular function and structure during continuous flow LVAD support, but also a clear association of the degree of alterations in vascular, baroreceptor, and sympathetic nervous system function with the degree of actual pulsatility. In addition, a number of clinical events have been linked to continuous flow LVAD physiology, including a decreased extent of ventricular unloading possibly impairing myocardial recovery, hemolysis and device thrombosis, development of aortic insufficiency, and mucosal bleeding. Summary Many of the adverse effects of the current continuous flow LVADs are associated with low pulsatile flow. An evolved understanding of pulsatility as a continuous rather than a binary variable may allow us to incorporate appropriate degrees of pulsatility into the next generation pumps and mitigate these effects.

Original languageEnglish (US)
Pages (from-to)329-336
Number of pages8
JournalCurrent Opinion in Cardiology
Volume31
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Heart-Assist Devices
Blood Vessels
Pulsatile Flow
Equipment and Supplies
Pressoreceptors
Sympathetic Nervous System
Hemolysis
Thrombosis
Heart Failure
Hemorrhage

Keywords

  • Adverse events
  • Continuous flow left ventricular assist device
  • Pulsatility

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{cd0aa89f03f149a3af0eef95e0edc9a6,
title = "Creating adequate pulsatility with a continuous flow left ventricular assist device: Just do it!",
abstract = "Purpose of review Continuous flow left ventricular assist devices (LVADs) have revolutionized the treatment of advanced heart failure; however, as experience with these devices has grown, a number of unanticipated adverse events have emerged. In this study, we review the current literature associating a lack of pulsatility with these events. Recent findings It is now evident that continuous flow LVAD physiology reflects a spectrum of 'low pulsatile' rather than a truly 'nonpulsatile' state. Thus, the detrimental consequences of nonpulsatile flow noted in early experimental setups may or may not occur in humans supported with continuous flow LVADs. Such studies have demonstrated not only alterations in vascular function and structure during continuous flow LVAD support, but also a clear association of the degree of alterations in vascular, baroreceptor, and sympathetic nervous system function with the degree of actual pulsatility. In addition, a number of clinical events have been linked to continuous flow LVAD physiology, including a decreased extent of ventricular unloading possibly impairing myocardial recovery, hemolysis and device thrombosis, development of aortic insufficiency, and mucosal bleeding. Summary Many of the adverse effects of the current continuous flow LVADs are associated with low pulsatile flow. An evolved understanding of pulsatility as a continuous rather than a binary variable may allow us to incorporate appropriate degrees of pulsatility into the next generation pumps and mitigate these effects.",
keywords = "Adverse events, Continuous flow left ventricular assist device, Pulsatility",
author = "Patel, {Snehal R.} and Jorde, {Ulrich P.}",
year = "2016",
doi = "10.1097/HCO.0000000000000283",
language = "English (US)",
volume = "31",
pages = "329--336",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Creating adequate pulsatility with a continuous flow left ventricular assist device

T2 - Just do it!

AU - Patel, Snehal R.

AU - Jorde, Ulrich P.

PY - 2016

Y1 - 2016

N2 - Purpose of review Continuous flow left ventricular assist devices (LVADs) have revolutionized the treatment of advanced heart failure; however, as experience with these devices has grown, a number of unanticipated adverse events have emerged. In this study, we review the current literature associating a lack of pulsatility with these events. Recent findings It is now evident that continuous flow LVAD physiology reflects a spectrum of 'low pulsatile' rather than a truly 'nonpulsatile' state. Thus, the detrimental consequences of nonpulsatile flow noted in early experimental setups may or may not occur in humans supported with continuous flow LVADs. Such studies have demonstrated not only alterations in vascular function and structure during continuous flow LVAD support, but also a clear association of the degree of alterations in vascular, baroreceptor, and sympathetic nervous system function with the degree of actual pulsatility. In addition, a number of clinical events have been linked to continuous flow LVAD physiology, including a decreased extent of ventricular unloading possibly impairing myocardial recovery, hemolysis and device thrombosis, development of aortic insufficiency, and mucosal bleeding. Summary Many of the adverse effects of the current continuous flow LVADs are associated with low pulsatile flow. An evolved understanding of pulsatility as a continuous rather than a binary variable may allow us to incorporate appropriate degrees of pulsatility into the next generation pumps and mitigate these effects.

AB - Purpose of review Continuous flow left ventricular assist devices (LVADs) have revolutionized the treatment of advanced heart failure; however, as experience with these devices has grown, a number of unanticipated adverse events have emerged. In this study, we review the current literature associating a lack of pulsatility with these events. Recent findings It is now evident that continuous flow LVAD physiology reflects a spectrum of 'low pulsatile' rather than a truly 'nonpulsatile' state. Thus, the detrimental consequences of nonpulsatile flow noted in early experimental setups may or may not occur in humans supported with continuous flow LVADs. Such studies have demonstrated not only alterations in vascular function and structure during continuous flow LVAD support, but also a clear association of the degree of alterations in vascular, baroreceptor, and sympathetic nervous system function with the degree of actual pulsatility. In addition, a number of clinical events have been linked to continuous flow LVAD physiology, including a decreased extent of ventricular unloading possibly impairing myocardial recovery, hemolysis and device thrombosis, development of aortic insufficiency, and mucosal bleeding. Summary Many of the adverse effects of the current continuous flow LVADs are associated with low pulsatile flow. An evolved understanding of pulsatility as a continuous rather than a binary variable may allow us to incorporate appropriate degrees of pulsatility into the next generation pumps and mitigate these effects.

KW - Adverse events

KW - Continuous flow left ventricular assist device

KW - Pulsatility

UR - http://www.scopus.com/inward/record.url?scp=84963691739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963691739&partnerID=8YFLogxK

U2 - 10.1097/HCO.0000000000000283

DO - 10.1097/HCO.0000000000000283

M3 - Article

C2 - 27054506

AN - SCOPUS:84963691739

VL - 31

SP - 329

EP - 336

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 3

ER -